Back to Insider Trading View Full Company Profile

XERS

HEALTHY

Xeris Biopharma Holdings, Inc.

CIK: 0001867096

Strong Sell (70% confidence)

Last activity: 1 weeks ago

Financial Metrics

As of Dec 31, 2024 (10-K)

Revenue $163.91M
Net Income -$94.66M
Total Cash $67.27M

Insider Roster (5 total, 5 active)

Insider Buys Sells Net Value Holdings
JOHNSON JOHN
DIRECTOR
0 1 -$977K
698,083 shares
$5.04M
Hecht Beth
See Remarks
0 3 -$365K
1,243,174 shares
$9.26M
Shannon John Patrick Jr
See Remarks
0 1 -$176K
2,705,346 shares
$19.14M
McCulloch Kevin
See Remarks
0 1 -$120K
1,685,426 shares
$13.48M
BORMANN-KENNEDY BARBARA-JEAN ANNE
DIRECTOR
0 1 -$106K
142,500 shares
$1.01M

Recent Transactions

SELL Hecht Beth (See Remarks)

16,667 shares @ $7.45

$124K

Feb 2, 2026

Conviction: | View SEC Filing →
SELL McCulloch Kevin (See Remarks)

15,000 shares @ $8.00

$120K

Jan 8, 2026

Conviction: | View SEC Filing →
SELL Shannon John Patrick Jr (See Remarks)

24,907 shares @ $7.08

$176K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Hecht Beth (See Remarks)

16,667 shares @ $7.43

$124K

Jan 2, 2026

Conviction: | View SEC Filing →
SELL JOHNSON JOHN (DIRECTOR)

135,400 shares @ $7.22

$977K

Dec 19, 2025

Conviction: | View SEC Filing →
SELL BORMANN-KENNEDY BARBARA-JEAN ANNE (DIRECTOR)

15,000 shares @ $7.09

$106K

Dec 12, 2025

Conviction: | View SEC Filing →
SELL Hecht Beth (See Remarks)

16,667 shares @ $7.01

$117K

Dec 1, 2025

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.